Digestive System Diseases

All Conditions

Neoplasms

Symptoms and General Pathology

Colonic Diseases

Colonic Neoplasms

Adenoma

Colonic Polyps

Polyps

Rectal Diseases

Colorectal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Intestinal Neoplasms

Gastrointestinal Diseases

Intestinal Diseases

Pathological Conditions, Anatomical

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Participants who provide informed consent, meet the eligibility criteria and provide a blood sample for this study will be enrolled. Participants will undergo blood collection and will then complete a standard-of-care screening colonoscopy.

Freenome test

Aasma Shaukat, MD MPH

Theodore R Levin, MD

Lance Baldo, MD

The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Freenome is using a type of artificial intelligence, called machine learning, to identify patterns of cell-free biomarkers in blood to detect cancer early. The purpose of this prospective multi-center observational study is to validate a blood-based test for the detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Blood specimens will be de-identified and used to validate the performance characteristics of the Freenome test.

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Freenome Holdings Inc.

Spots Global Cancer Trial Database for gastrointestinal tract cancers